Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

After China Trade Deal, Trump Takes Aim at Europe

The Trump administration has taken a tough stance in international trade negotiations. With the US-China deal sealed and Congress set to vote on the US-Mexico-Canada accord, will the European Union be President Trump’s next target? Kenny Fisher ...

Is Trump Reversing Course On Iran?

The Trump administration is attempting to dial down the tension with Iran, lowering the risk of military conflict and pushing for diplomatic negotiations. On Sunday, U.S. Secretary of State Mike Pompeo said that the U.S. was ready to negotiate with Iran with "no precondi...

Gilead, Teva, XPhyto - Global marketing potential

The best business models solve problems and are scalable. In this context, the healthcare sector is particularly interesting. The world's population has recently reached 7.8 billion people and for this reason solutions can meet a large potential market with users. Cross-border...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

What is the future of oil and gas?

Population growth will be a massive factor on increased energy demands The International Energy Agency states that at present we are “maintaining the 2021 energy crisis” The push for renewables as we head towards 2050 doesn&CloseC...

Market Open: Jan 20 | Markets Eye Trump’s Inauguration Amid MLK Day Lull

North of the border, Canadian markets remain robust, holding last week’s gains. Market Numbers: TSX : Up (0.89%) 25,067.92 TSXV: Up (1.30%) 616.34 DOW: Up (0.78%) 43,487.83 NASDAQ: Up (1.51%) 19,630.20 FTSE: Up(0.12%) 8,515.85 ...

Financial Crisis 2008: Is the Story Going to Repeat?

The coming year has the potential for a combination of major risks to the global economy coming together to cause a financial crisis rivaling that of 2008-09. The mortgage bubble that burst in 2008 led to multiple failures of financial institutions, major downturns in global...

CVS Declares Quarterly Dividend and Gets a Boost from Relaxed Rebate Policy

CVS Healthcare announced a $0.50/share quarterly dividend yesterday and got an added boost today as news spreads regarding easing of federal restrictions on pharmacy rebate plans. CVS Health Corp. (CVS:NYSE) along with many other pharmacy benefits manag...

2021: A Breakout Year for Uranium Investments?

(Image via Anfield Energy Inc.) The Athabasca Basin is perhaps best known as the world’s leading source of high-grade uranium and currently supplies about 20% of the world’s uranium. It is a region in the Canadian Shield that enco...

Buzz on the Bullboards: Stocks making headlines - Baytex, New Found Gold, Theralase

After a tough two-day drop, Canada’s main stock index rallied on Wednesday following reports that the US administration was considering relaxing the strict tariffs on imports from Canada and Mexico. What the “Buzz” ...
1 2 3 4 5 6 7 8 9 10 ...